Involvement of nitric oxide in phencyclidine-induced place aversion and preference in mice

Yoshiaki Miyamoto, Yukihiro Noda, Yumiko Komori, Hishayoshi Sugihara, Hiroshi Furukawa, Toshitaka Nabeshima

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The present study investigated the involvement of nitric oxide (NO) in phencyclidine (PCP)-induced place aversion and preference in the place conditioning paradigm. PCP-induced place aversion in naive mice was dose-dependently attenuated by administration of N(G)-nitro-L-arginine methyl ester (L-NAME), a NO synthase (NOS) inhibitor, during the conditioning. The NOS activity and dopamine (DA) turnover in the hippocampus in mice showing PCP-induced place aversion were decreased, such changes being restored by administration of L-NAME during the conditioning. On the other hand, PCP-induced place preference in mice pretreated with PCP for 28 days was not attenuated by administration of L-NAME during the conditioning. Although NOS activity was not changed, the DA turnover in the cerebral cortex was increased in mice showing PCP-induced place preference. In mice pretreated with L-NAME and PCP for 28 days before the place conditioning paradigm, PCP neither induced place preference, nor changed the NOS activity or DA turnover. These results suggest that NO is involved in the acquisition of PCP-induced aversive effects, and in the development of PCP-induced preferred effects. Further, the functional change of the DAergic neuronal system mediated by NO in the hippocampus and cerebral cortex may be necessary for the expression of aversive effects and development of preferred effects, respectively, induced by PCP. (C) 2000 Elsevier Science B.V.

Original languageEnglish
Pages (from-to)187-196
Number of pages10
JournalBehavioural Brain Research
Volume116
Issue number2
DOIs
Publication statusPublished - 05-12-2000
Externally publishedYes

Fingerprint

Phencyclidine
NG-Nitroarginine Methyl Ester
Nitric Oxide
Nitric Oxide Synthase
Dopamine
Cerebral Cortex
Hippocampus

All Science Journal Classification (ASJC) codes

  • Behavioral Neuroscience

Cite this

Miyamoto, Yoshiaki ; Noda, Yukihiro ; Komori, Yumiko ; Sugihara, Hishayoshi ; Furukawa, Hiroshi ; Nabeshima, Toshitaka. / Involvement of nitric oxide in phencyclidine-induced place aversion and preference in mice. In: Behavioural Brain Research. 2000 ; Vol. 116, No. 2. pp. 187-196.
@article{feb8bc8ae798490b8a786215d1191191,
title = "Involvement of nitric oxide in phencyclidine-induced place aversion and preference in mice",
abstract = "The present study investigated the involvement of nitric oxide (NO) in phencyclidine (PCP)-induced place aversion and preference in the place conditioning paradigm. PCP-induced place aversion in naive mice was dose-dependently attenuated by administration of N(G)-nitro-L-arginine methyl ester (L-NAME), a NO synthase (NOS) inhibitor, during the conditioning. The NOS activity and dopamine (DA) turnover in the hippocampus in mice showing PCP-induced place aversion were decreased, such changes being restored by administration of L-NAME during the conditioning. On the other hand, PCP-induced place preference in mice pretreated with PCP for 28 days was not attenuated by administration of L-NAME during the conditioning. Although NOS activity was not changed, the DA turnover in the cerebral cortex was increased in mice showing PCP-induced place preference. In mice pretreated with L-NAME and PCP for 28 days before the place conditioning paradigm, PCP neither induced place preference, nor changed the NOS activity or DA turnover. These results suggest that NO is involved in the acquisition of PCP-induced aversive effects, and in the development of PCP-induced preferred effects. Further, the functional change of the DAergic neuronal system mediated by NO in the hippocampus and cerebral cortex may be necessary for the expression of aversive effects and development of preferred effects, respectively, induced by PCP. (C) 2000 Elsevier Science B.V.",
author = "Yoshiaki Miyamoto and Yukihiro Noda and Yumiko Komori and Hishayoshi Sugihara and Hiroshi Furukawa and Toshitaka Nabeshima",
year = "2000",
month = "12",
day = "5",
doi = "10.1016/S0166-4328(00)00274-6",
language = "English",
volume = "116",
pages = "187--196",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",
number = "2",

}

Involvement of nitric oxide in phencyclidine-induced place aversion and preference in mice. / Miyamoto, Yoshiaki; Noda, Yukihiro; Komori, Yumiko; Sugihara, Hishayoshi; Furukawa, Hiroshi; Nabeshima, Toshitaka.

In: Behavioural Brain Research, Vol. 116, No. 2, 05.12.2000, p. 187-196.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Involvement of nitric oxide in phencyclidine-induced place aversion and preference in mice

AU - Miyamoto, Yoshiaki

AU - Noda, Yukihiro

AU - Komori, Yumiko

AU - Sugihara, Hishayoshi

AU - Furukawa, Hiroshi

AU - Nabeshima, Toshitaka

PY - 2000/12/5

Y1 - 2000/12/5

N2 - The present study investigated the involvement of nitric oxide (NO) in phencyclidine (PCP)-induced place aversion and preference in the place conditioning paradigm. PCP-induced place aversion in naive mice was dose-dependently attenuated by administration of N(G)-nitro-L-arginine methyl ester (L-NAME), a NO synthase (NOS) inhibitor, during the conditioning. The NOS activity and dopamine (DA) turnover in the hippocampus in mice showing PCP-induced place aversion were decreased, such changes being restored by administration of L-NAME during the conditioning. On the other hand, PCP-induced place preference in mice pretreated with PCP for 28 days was not attenuated by administration of L-NAME during the conditioning. Although NOS activity was not changed, the DA turnover in the cerebral cortex was increased in mice showing PCP-induced place preference. In mice pretreated with L-NAME and PCP for 28 days before the place conditioning paradigm, PCP neither induced place preference, nor changed the NOS activity or DA turnover. These results suggest that NO is involved in the acquisition of PCP-induced aversive effects, and in the development of PCP-induced preferred effects. Further, the functional change of the DAergic neuronal system mediated by NO in the hippocampus and cerebral cortex may be necessary for the expression of aversive effects and development of preferred effects, respectively, induced by PCP. (C) 2000 Elsevier Science B.V.

AB - The present study investigated the involvement of nitric oxide (NO) in phencyclidine (PCP)-induced place aversion and preference in the place conditioning paradigm. PCP-induced place aversion in naive mice was dose-dependently attenuated by administration of N(G)-nitro-L-arginine methyl ester (L-NAME), a NO synthase (NOS) inhibitor, during the conditioning. The NOS activity and dopamine (DA) turnover in the hippocampus in mice showing PCP-induced place aversion were decreased, such changes being restored by administration of L-NAME during the conditioning. On the other hand, PCP-induced place preference in mice pretreated with PCP for 28 days was not attenuated by administration of L-NAME during the conditioning. Although NOS activity was not changed, the DA turnover in the cerebral cortex was increased in mice showing PCP-induced place preference. In mice pretreated with L-NAME and PCP for 28 days before the place conditioning paradigm, PCP neither induced place preference, nor changed the NOS activity or DA turnover. These results suggest that NO is involved in the acquisition of PCP-induced aversive effects, and in the development of PCP-induced preferred effects. Further, the functional change of the DAergic neuronal system mediated by NO in the hippocampus and cerebral cortex may be necessary for the expression of aversive effects and development of preferred effects, respectively, induced by PCP. (C) 2000 Elsevier Science B.V.

UR - http://www.scopus.com/inward/record.url?scp=0034610512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034610512&partnerID=8YFLogxK

U2 - 10.1016/S0166-4328(00)00274-6

DO - 10.1016/S0166-4328(00)00274-6

M3 - Article

VL - 116

SP - 187

EP - 196

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

IS - 2

ER -